Cancer survival data emphasise importance of early diagnosis

doi:10.1136/bmj.l408

Paper

Cancer survival data emphasise importance of early diagnosis

Published Jan 25, 2019 · N. Hawkes

British Medical Journal

Q1 SJR score

131

Citations

4

Influential Citations

Full textSemantic Scholar

Abstract

Robust cancer survival estimates according to stage at diagnosis have been published by the Office for National Statistics for the first time.1 They show, as expected, that for most cancers survival at one and five years is much higher if the cancer is detected early (at stage 1) than if it is detected later. This re-emphasises the need for early diagnosis. For some cancers, however, the stage of detection is less important. Prostate cancer, for example, has extremely high one year survival rates (around 100%) whether it is detected in stages 1, 2, or 3, falling to 87.6% if detected in stage 4. Five year survival follows a similar but steeper decline—100% or near for stages …

Rigorous Journal

Highly Cited

Study Snapshot

Early diagnosis is crucial for most cancers, with higher survival rates at one and five years if detected early.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Cancer survival data emphasise importance of early diagnosis

Sign up to use Study Snapshot

References

Citations

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications

MUC1 plays a crucial role in pancreatic cancer onset and progression, and may serve as a biomarker and novel therapeutic target for pancreatic adenocarcinoma treatment.

Global, regional, and national trends in colorectal cancer burden from 1990 to 2021 and projections to 2040

CRC remains a significant public health issue with regional and gender differences, requiring region- and population-specific prevention strategies.

Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine

Volatile organic compounds in urine and olfactory receptors in living organisms show potential for accurate early-stage cancer detection.

Cell-free DNA end characteristics enable accurate and sensitive cancer diagnosis

Cell-free DNA end characteristics, specifically those within nucleosomes, can enable accurate and sensitive cancer diagnosis by revealing significant alterations in patients with cancer.

When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock

Tumour development varies with age, season, and circadian rhythm, with immunity and metabolism playing key roles in shaping these variations.

The impact of statins on melanoma survival: a systematic review and meta-analysis.

Statin use may improve 5-year overall survival in melanoma patients, but the wide 95% CIs and type II error risk create significant uncertainty.

An Open-Source BioMEMS Platform for Generalized Early Cancer Detection

This open-source biosensing framework can detect diverse types of cancer simultaneously or with enhanced sensitivity, improving early cancer detection and survival rates.